Why hospitals mergers fail to improve care

Amy Baxter | | Health Exec | Quality
Hospital staff walking through a medical facility, intentionally blurred to look artistic

Healthcare mergers and acquisition has been on a hot streak for a number of years, but not all hospital mergers end up achieving their stated goals. For instance, hospital mergers may actually increase prices rather than decrease them.

This means that what hospitals say and what they do is actually quite different, Robert Pearl, MD, a Stanford University professor, wrote in Forbes. In addition, there are three reasons why hospital mergers will “fail to improve American healthcare in the future,” according to Pearl.

Here are the three reasons:

  1. Cost containment isn’t a goal––promises to reduce waste and increase savings to payers simply aren’t true.
  2. Quality doesn’t improve without changes in care delivery––hospital consolidations don’t actually improve care delivery.
  3. Hospital revenues hurt by technologies to improve patient care––while new technologies like 3D-printed implants and robotic surgeries attract patients, they don’t actually improve care.

See the full story below:

3 Reasons Hospital Mergers Fail

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system
FDA commissioner urges health systems to strengthen AI quality oversight
The top 25 children's heart hospitals in the US
Study ranks US health system dead last among wealthy nations
The 25 top US hospitals for diabetes care
The 25 best heart hospitals in the United States

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”